Dr. Martens (LON:DOCS) Trading 17.4% Higher - What's Next?

Dr. Martens plc (LON:DOCS - Get Free Report)'s share price traded up 17.4% during mid-day trading on Thursday . The stock traded as high as GBX 71.95 ($0.97) and last traded at GBX 70.40 ($0.95). 5,243,139 shares changed hands during trading, an increase of 136% from the average session volume of 2,224,596 shares. The stock had previously closed at GBX 59.95 ($0.81).

Analysts Set New Price Targets

Separately, Royal Bank of Canada lowered their price target on shares of Dr. Martens from GBX 7,000 ($94.75) to GBX 6,000 ($81.21) and set a "sector perform" rating for the company in a report on Monday, May 19th.

Dr. Martens Stock Up 8.7%

The firm's 50 day moving average price is GBX 55.34 and its two-hundred day moving average price is GBX 62.91. The company has a market cap of £795.54 million, a P/E ratio of 11.62, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.

Dr. Martens (LON:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Equities research analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Dr. Martens Cuts Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were paid a GBX 0.85 ($0.01) dividend. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio is currently 42.53%.

Insider Activity

In other Dr. Martens news, insider Giles Wilson purchased 32,640 shares of Dr. Martens stock in a transaction that occurred on Tuesday, March 25th. The stock was acquired at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,857.07). Insiders purchased 33,206 shares of company stock worth $1,792,771 in the last quarter. 4.36% of the stock is owned by corporate insiders.

Dr. Martens Company Profile

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.